The British Pound has fallen during the early hours here on Tuesday against the US dollar again, but really, at this point in time, we seem to be just hanging around the 1.34 level.
The 1.34 level is an area that I think is important because it is in the middle of the overall consolidation range that we had been in.
The 50-day EMA sits just above, and that causes some resistance as well, but what I really find interesting is that we sliced through a major uptrend line, fell to the 200-day EMA about a week ago, bounced from there, and then failed at that previous uptrend line in the 50-day EMA also.
With this, I think you’ve got a situation where the market will probably continue to see a lot of resistance above. And therefore, I do prefer shorting this pair if I have a position.
I Use This as an Indicator
Truthfully, my favorite use for this market is to see how the US dollar is performing because if it’s strengthening here, it’s really going to put a beating on something like the euro, typically. With this, I look at the fact that the British pound has been so strong over the last couple of years in comparison to the euro, the yen, the Canadian dollar, and other currencies, and I use this as a secondary and even tertiary indicator with other trades.
If I had to put a position on would be short here, but I think the 200-day EMA will continue to be a bit stubborn. If we were to break down below the 1.32 level, then I think the bottom falls out, and in that environment, you are more likely than not to see the US dollar strengthening against multiple currencies.
If this market breaks above the 1.35 level, then maybe we go back to the 1.36 level, but that still doesn’t have us breaking out of the range. All things being equal, I think we’re drifting lower.
Christopher Lewis has been trading Forex and has over 20 years experience in financial markets. Chris has been a regular contributor to Daily Forex since the early days of the site. He writes about Forex for several online publications, including FX Empire, Investing.com, and his own site, aptly named The Trader Guy. Chris favours technical analysis methods to identify his trades and likes to trade equity indices and commodities as well as Forex. He favours a longer-term trading style, and his trades often last for days or weeks.
This sector is growing faster than many other markets with a compound annual growth rate (CAGR) of 4% and countries like the UK and France showing steadily increasing demand.
While Germany and Italy currently lead spending on memory and mood supplements (accounting for 26% and 18% of Western Europe, respectively), these figures are beginning to plateau.
In contrast, the UK and France—which represent 14% and 13% of the market—are expanding at twice the rate of other Western European countries. Other fast-growing markets include Finland, Greece, Spain and Sweden.
There is also an interesting evolution happening in the sector, according to Nick Stene, Euromonitor’s senior global insight manager for consumer health, who said mood and relaxation are quickly becoming just as sought after as cognition and memory.
“Underlying this market growth is a large shift in emphasis,” he said. “Ten years ago, the split was 60/40 for memory and cognitive spend to mood and anxiety spend, but today that split is closer to 50/50, with spend on mind health such as mood, relaxation and reduced anxiety rising quickly.”
Euromonitor forecasts the mind health supplement market to continue to grow at a fast rate due to hype around new ingredients, particularly those targeting cellular health.
“The expectation from the sector is that the cognitive aspect will likely accelerate due to recent cellular health messaging from emerging ingredients like NAD+ and resveratrol that we see resonating with consumers and driving fast growth in 2025,” Stene said.
What’s trending in the mind health market?
Earlier this year, Innova Market Insights published a report assessing global consumer trends in supplement and beverage ingredients for mental performance. The report found that, overall, growth in this market is extremely strong, with nearly one in five product launches carrying a mental performance claim.
B vitamins were cited as the leading supplement for brain health, followed by other vitamins, minerals and omega-3s. These ingredients are highly trusted by consumers and are frequently incorporated into food, beverages and supplements aimed at enhancing mental performance.
An increasing number of consumers are also seeking cognitive benefits from probiotics, botanicals and functional mushrooms, with lion’s mane and ashwagandha among the most popular.
Data also shows a shift in consumer preference away from traditional formats like powders and capsules towards carbonated soft drinks and functional hot drinks, which are quickly gaining traction. This trend is largely driven by younger consumers, who are the most likely to purchase products for brain health. However, the report highlights that older consumers represent an untapped market with significant potential.
Reflecting this trend, Scotland-based brand Love Mushrooms has observed a significant surge in interest among middle-aged and older women, likely driven by menopause-related symptoms such as brain fog, memory problems, poor concentration and anxiety.
“Interest spans all ages, but we’re seeing a surge among women aged 35 and over, particularly those navigating perimenopause and menopause,” said Rachael Hall, director of health and beauty at Love Mushrooms. “There’s also rising curiosity among younger adults seeking natural alternatives to pharmaceuticals.”
But what are consumers looking for when it comes to mushroom supplements? And which species are consumers reaching for the most?
Mushrooms: A ‘multi-pathway approach’
Functional mushrooms offer a multi-pathway approach to mind health, according to Hall, who said lion’s mane, reishi and cordyceps are trending within the category.
“Many functional mushrooms act as adaptogens, supporting the body’s ability to cope with mental and emotional stressors,” she said. “Research suggests that species like lion’s mane stimulate nerve growth factor, supporting general cognition, neuroplasticity and memory, while reishi and cordyceps are known to modulate stress response via the HPA axis, helping balance cortisol and promoting calm focus.”
Hall highlighted that lion’s mane has entered the mainstream, propelled by emerging scientific research and media exposure, with major UK supermarkets such as Sainsbury’s and Tesco’s now stocking this ingredient.
Lion’s Mane Mushroom (wavipicture/Getty Images)
Within the active nutrition sector, cordyceps has grown in popularity due to its reported ability to increase mental stamina and energy, benefits especially valued by consumers who avoid caffeine. This appears to correlate with the top three concerns consumers aim to address—focus, memory and stress relief—which are particularly important to individuals navigating neurodiversity and hormonal shifts, Hall said.
“We also see growing interest in emotional regulation, sleep quality and mental clarity/brain fog, especially among those living high pressure lifestyles,” she added.
Other trends in the category include supplement stacking—combining mushrooms with other mushrooms or botanical ingredients—along with personalization and education-first branding.
“Overall, consumer awareness is deepening as more brands rise up and big retailers start to stock products,” Hall said. “People are asking smarter questions and seeking transparency around efficacy, extraction and bioavailability.”
Botanicals for stress and fatigue
Botanicals have long been a cornerstone of the mind health supplements market, with plant extracts such as ashwagandha, ginseng, ginkgo biloba and bacopa extensively studied for their potential brain benefits.
With stress and poor sleep increasingly recognized for their negative effects on mind and mood, Laura López, head of product research, development and innovation at Spanish botanical extract supplier Nektium, predicts a surge in demand for botanicals targeting these consumer concerns.
“Over the next five years, the botanicals market for cognition and mind health is likely to evolve rapidly,” she said. “It’ll be driven by growing consumer demand for natural solutions with evidence-based benefits such as mental energy, focus, mood support, stress resilience and long-term brain health. Sleep will continue to be an area of great importance too.
“There will also be increasing emphasis on clinical evidence, quality, provenance and sustainability. Growth in multi-benefit formulations and functional formats such as beverages and snacks will further broaden the category’s reach.”
López also noted a growing aversion to caffeine, with consumers now increasingly turning to adaptogens as a natural solution for stress and fatigue. Despite its capacity to improve mood and performance even at relatively low doses, concerns about side effects such as anxiety and sleep disturbance are prompting consumers to search out more natural energy boosters.
While ashwagandha remains popular as a promoter of calm alertness and stress resilience, López pointed out that its 2023 ban in Denmark has led to growing interest in alternative ingredients.
“Rhodiola rosea has really benefited from this,” she said. “It has a long history of traditional use for its ability to support the mind and body in adapting to stress, helping to reduce fatigue and increase endurance. Because of that, many consumers are using it to restore balance, maintain well-being and cope with the challenges of modern life.”
She also noted increasing consumer concern surrounding inconsistent bioactive standardization, poor quality extracts and the risk of adulteration. This is driving demand for better quality plant products which are backed up by high-quality scientific research.
“Plant materials can be tainted or replaced with lookalikes, leading to inferior products being passed off as high-quality extracts,” she said. “The push for transparency, traceability and strong clinical evidence to back up benefits provides an advantage for sustainably sourced and identity-guaranteed products.”
Rhodiola rosea is a perennial herb that mostly grows at high altitudes in arctic areas of Europe and Asia. As an adaptogen, the herb is recognized for its ability to mitigate physiological responses to stress. (Ideas_Studio/Getty Images/iStockphoto)
Vitamins, minerals and omega-3s for cognitive function
Although the mushroom and botanical markets are growing quickly, vitamins, minerals and omega-3s still lead the way as the most popular supplements for mind health.
B vitamins are perhaps the most widely recognized for their cognitive benefits, with folate, vitamin B12 and B6 all extensively studied for their positive effects on brain function.
Zinc, iron, iodine and magnesium also have EFSA-approved health claims related to cognitive function, substantiating their brain health benefits, as does DHA (docosahexaenoic acid),a marine omega-3 found in fish.
Omega-3 fatty acids have long been touted as an integral nutrient for brain health, with clinical data showing that it supports cognitive function by maintaining cell structure, improving neurotransmitter release and reducing inflammation.
As the most abundant polyunsaturated fatty acid in the brain, DHA is the most studied form of omega-3, according to Dr. Derek Tobin, business development and clinical science manager at Epax, a Norwegian supplier of marine ingredients.
“DHA is important in the structure and function of the brain,” he said. “At a cellular level, DHA helps the nerves to efficiently communicate. It is also a precursor to important signaling molecules such as endocannabinoids and as a stimulator of the neuroprotectant, BDNF.”
Eicosapentaenoic acid (EPA) is another type of omega-3 fatty acid found primarily in fish and in small amounts in the human brain.
“While DHA makes up 90% of omega-3 in the brain, EPA is almost indetectable,” Tobin said. “Despite this, there is widespread evidence that EPA is important in wellness, mood and depression. Several guidelines recommend one to two grams of EPA daily using a high EPA:DHA ratio oil for the nutritional management of depression.”
Algae and krill oil are also significant source of beneficial fatty acids and are gaining traction due to consumer sustainability concerns.
“There is definitely growing recognition of algae oil as a sustainable and effective source of omega-3 for mind health,” said Christel Lemaire, marketing manager at French microalgae ingredient supplier Microphyt. “Consumers today are increasingly aware that brain health matters at every stage of life, from academic performance to healthy aging. Sustainability and purity are also strong drivers of interest.”
She added that within a broader and expanding algae-based ingredients market, the microalgae segment is progressing more gradually. This slower growth is mainly due to limited consumer awareness and regulatory constraints, as only eight species of microalgae are currently approved for human consumption worldwide.
Other omegas are also beginning to gain traction, according to Tobin, with early research suggesting that omega-9 and omega-11 may also support brain health.
“With regards to other omegas, there are several studies showing olive oil, with omega-9, as part of the Mediterranean diet promotes cognitive function and slows cognitive decline in the elderly,” he said. “The effects of marine derived omega-9 (gondoic acid), as well as omega-11 (cetoleic acid) on brain health are at early stages of research with current research ongoing on the effects of cetoleic acid on [cognitive decline].”
Cellular health: An emerging category for brain health
Euromonitor is also paying close attention to the emerging cellular health category, with NAD+ variants among the fastest-growing ingredients in the market, according to Stene.
While cellular health supplements typically make claims related to longevity and healthspan, he noted that these ingredients can also benefit brain health, with preclinical models suggesting improvements to cognitive function and reduced neuroinflammation.
“NAD+ variants are the most disruptive [supplement category] so far,” Stene said. “Health claims linked to this ingredient on supplements include supporting energy production, DNA repair and healthy aging, with potential benefits implied for metabolism, brain and heart health.”
Euromonitor reported that around 6% of supplements launched since July 2024 carried some form of NAD+ messaging, equating to around one in 10 longevity supplements. Stene described this as an ‘escaping niche’ which is rising far faster than many industry teams expected.
The data suggests the polyphenol resveratrol is also gaining in popularity, although it is currently only featured in 2% of new SKUs launched since July 2024. This is an intriguing finding given the ingredient’s somewhat controversial past linking it to overhyped claims and mixed clinical evidence.
Resveratrol rose to prominence in the early 2000s after research by David Sinclair—a professor of genetics at Harvard Medical School—showed that resveratrol may activate SIRT-1, a protein that plays a crucial role in cellular processes and has been linked to lifespan extension.
However, when researchers tried to replicate this in vitro finding in mice, no lifespan extension was observed. In humans, resveratrol has also failed to demonstrate any lifespan benefits.
Despite resveratrol’s paradoxical past, Stene noted that scientists are now exploring its potential to protect against cognitive decline, contributing to its resurgence.
“This antioxidant ingredient is linked to some of the hopes surrounding this sector for finding ways to protect against neurodegenerative disease,” Stene said. “Human evidence of benefits is limited and mixed and at an earlier stage of testing, but this is opening up messaging around cell senescence, sirtuin stimulation, memory and cognitive function.”
The market is glued to one topic right now: the XRP price prediction. Momentum has cooled after a rapid climb, and traders want to know if strength can stretch or if the next leg belongs to newer payment tokens. There is a rising PayFi altcoin quietly pulling liquidity toward itself, and seasoned investors are watching it for the next powerful move. That altcoin is Remittix.
The XRP price prediction sits at the center stage because the token anchors cross-border narratives and liquidity flows. Yet capital rotates fast when fresh utility arrives, and the hunt for real-world settlement at low cost is creating a narrow window for early entries elsewhere. Keep that in mind as we look at the data.
XRP Price Today and Analyst Outlook
XRP trades near $2.48 after a choppy week. That keeps the daily gain around 4.15%, but the tape shows signs of range behavior. Several desks frame their XRP price prediction in a band between $2.39 and $2.48 through October 2025, with a possible push toward $2.77 if volumes return. Others flag cooling order books and sideways chop while Fear and Greed slips.
Even with mixed sentiment, liquidity networks and exchange access still support the bull case. The key test is whether catalysts can refresh demand quickly. Without a new spark, the conservative XRP price prediction favors consolidation before any renewed extension. With one, the path opens to a retest of overhead zones into November.
Remittix: Emerging As A DeFi Powerhouse With Real World Impact
Now to that fast moving contender. Priced at $0.1166 today, Remittix is built for direct crypto to fiat settlement and has become a quiet favorite among early stage allocators. The team is verified by CertiK, and the project is currently ranked number 1 on CertiK for pre-Launch Tokens, which is a trust signal institutions notice.
Wallet beta testing is live with community users already putting it through real transactions. Compared with XRP, the angle here is speed to everyday usage and breadth of payout rails. Support spans more than 40 cryptocurrencies and 30 fiat currencies with real time FX conversion.
You can currently buy RTX at $0.1166, but pricing will not sit still if adoption keeps climbing. More than 40,000 investors have acquired RTX in recent months, and over $27.5 million has been raised with more than 679 million tokens sold.
Why This Token Is Gaining Traction
Global reach enables crypto transfers directly to bank accounts in over 30 countries.
Utility first design targets daily payments rather than speculation alone.
Security is reinforced through a full CertiK verification that boosts buyer confidence.
The mobile wallet is live in beta and already processing community tests.
If the XRP price prediction plays out as a range while the market waits for a fresh catalyst, the door is open for capital to chase newer payment rails that move faster, cost less, and already have users in a live wallet beta. With verified security, confirmed listings, and a still accessible entry, Remittix is the contender many believe can outpace the next phase while XRP reassesses its trend.
This article contains information about a cryptocurrency presale. Crypto Economy is not associated with the project. As with any initiative within the crypto ecosystem, we encourage users to do their own research before participating, carefully considering both the potential and the risks involved. This content is for informational purposes only and does not constitute investment advice.
The GBPJPY pair confirmed the stability of the bullish scenario by forming a new bullish rally yesterday, achieving the initial target by hitting 203.50 level, to settle above $161.8 Fibonacci extension level at 202.50.
The continuation of providing positive momentum by the main indicators will increase the strength of the bullish track, to expect attacking the barrier at 203.95, and surpassing it will open the way for reaching new stations that might begin from 204.60 and 205.25, while changing the trend and begin the bearish corrective track requires forming sharp decline to settle below the extra support at 201.70.
The expected trading range for today is between 202.60 and 203.95
EUR/USD struggles to stage a rebound early Wednesday and fluctuates in a tight channel at around 1.1600 after posting losses for three consecutive trading days. The pair’s technical outlook suggests that the bearish stance remains unchanged in the short term.
Euro Price This week
The table below shows the percentage change of Euro (EUR) against listed major currencies this week. Euro was the weakest against the New Zealand Dollar.
USD
EUR
GBP
JPY
CAD
AUD
NZD
CHF
USD
0.63%
0.87%
0.79%
-0.07%
-0.05%
-0.15%
0.55%
EUR
-0.63%
0.24%
0.26%
-0.69%
-0.57%
-0.84%
-0.06%
GBP
-0.87%
-0.24%
-0.24%
-0.93%
-0.81%
-1.08%
-0.32%
JPY
-0.79%
-0.26%
0.24%
-0.90%
-0.87%
-1.02%
-0.34%
CAD
0.07%
0.69%
0.93%
0.90%
0.06%
-0.15%
0.62%
AUD
0.05%
0.57%
0.81%
0.87%
-0.06%
-0.27%
0.52%
NZD
0.15%
0.84%
1.08%
1.02%
0.15%
0.27%
0.77%
CHF
-0.55%
0.06%
0.32%
0.34%
-0.62%
-0.52%
-0.77%
The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the Euro from the left column and move along the horizontal line to the US Dollar, the percentage change displayed in the box will represent EUR (base)/USD (quote).
The broad-based US Dollar (USD) strength caused EUR/USD to stay on the back foot on Tuesday. Easing fears over a deepening US-China trade conflict helped the sentiment surrounding the USD improve.
Meanwhile, investors might also be turning optimistic about the reopening of the US government soon. Following a meeting at the White House with President Donald Trump, some Republican senators said that Trump wants to end the government shutdown and that he is willing to talk to Democrats about it.
Later in the session, European Central Bank (ECB) President Christine Lagarde will deliver a keynote speech at Frankfurt Finance & Future Summit in Frankfurt. This will be Lagarde’s last public appearance before the ECB’s blackout period starts on Thursday. Nevertheless, Lagarde is unlikely to offer any comments that could significantly influence the market pricing of the ECB’s policy outlook.
In the absence of high-tier data releases, the risk perception could drive EUR/USD’s action in the second half of the day. At the time of press, US stock index futures were trading mixed. In case the market mood remains cautious in the American session, the pair could find it difficult to stage a rebound.
EUR/USD Technical Analysis
The Relative Strength Index (RSI) indicator on the 4-hour chart stays below 40 but it’s yet to drop below 30, suggesting that EUR/USD has more room on the downside before turning technically oversold.
The Fibonacci 61.8% retracement of the latest uptrend aligns as a key support level at 1.1580. If EUR/USD falls below this level, technical sellers could remain interested. In this scenario, 1.1550 (static level) could be seen as an interim support level before 1.1500 (Fibonacci 78.6% retracement).
Looking north, resistance levels could be seen at 1.1650 (100-day Simple Moving Average (SMA)), 1.1700 (50-day SMA) and 1.1765 (Fibonacci 23.6% retracement).
Euro FAQs
The Euro is the currency for the 19 European Union countries that belong to the Eurozone. It is the second most heavily traded currency in the world behind the US Dollar. In 2022, it accounted for 31% of all foreign exchange transactions, with an average daily turnover of over $2.2 trillion a day.
EUR/USD is the most heavily traded currency pair in the world, accounting for an estimated 30% off all transactions, followed by EUR/JPY (4%), EUR/GBP (3%) and EUR/AUD (2%).
The European Central Bank (ECB) in Frankfurt, Germany, is the reserve bank for the Eurozone. The ECB sets interest rates and manages monetary policy.
The ECB’s primary mandate is to maintain price stability, which means either controlling inflation or stimulating growth. Its primary tool is the raising or lowering of interest rates. Relatively high interest rates – or the expectation of higher rates – will usually benefit the Euro and vice versa.
The ECB Governing Council makes monetary policy decisions at meetings held eight times a year. Decisions are made by heads of the Eurozone national banks and six permanent members, including the President of the ECB, Christine Lagarde.
Eurozone inflation data, measured by the Harmonized Index of Consumer Prices (HICP), is an important econometric for the Euro. If inflation rises more than expected, especially if above the ECB’s 2% target, it obliges the ECB to raise interest rates to bring it back under control.
Relatively high interest rates compared to its counterparts will usually benefit the Euro, as it makes the region more attractive as a place for global investors to park their money.
Data releases gauge the health of the economy and can impact on the Euro. Indicators such as GDP, Manufacturing and Services PMIs, employment, and consumer sentiment surveys can all influence the direction of the single currency.
A strong economy is good for the Euro. Not only does it attract more foreign investment but it may encourage the ECB to put up interest rates, which will directly strengthen the Euro. Otherwise, if economic data is weak, the Euro is likely to fall.
Economic data for the four largest economies in the euro area (Germany, France, Italy and Spain) are especially significant, as they account for 75% of the Eurozone’s economy.
Another significant data release for the Euro is the Trade Balance. This indicator measures the difference between what a country earns from its exports and what it spends on imports over a given period.
If a country produces highly sought after exports then its currency will gain in value purely from the extra demand created from foreign buyers seeking to purchase these goods. Therefore, a positive net Trade Balance strengthens a currency and vice versa for a negative balance.
LOS ANGELES, Oct. 22, 2025 (GLOBE NEWSWIRE) — VeryVery Good Tea, the science-based beverage company modernizing tea for a new generation, has officially launched with the debut of its first product, Energy Tea. Backed by more than a dozen A-list investors including Donald Glover, Suki Waterhouse, Marcello Hernandez, Lindsey Vonn, Samuel L. Jackson, Diplo, Nick Viall, and Michael Strahan, with insight from a nationally recognized medical board, VeryVery keeps everything people have loved about tea for thousands of years while eliminating steep times, leafy water, and hidden microplastics.
The company’s first offering, Peach-flavored Energy Tea, blends black tea, green tea extract, and L-theanine to provide clean, sustained energy without the jitters, and can be enjoyed hot or cold. Unlike traditional tea that requires steeping and can taste leafy, VeryVery’s tea crystals mix instantly with water for a perfectly steeped taste.
“Tea is a massive, beloved category, but it hasn’t seen meaningful innovation in years,” said Tracy Ging, CEO of VeryVery Good Tea. “We saw an opportunity for VeryVery to modernize the category. It’s a product that meets evolving consumer expectations while creating a new growth opportunity in a category ripe for reinvention.”
The company’s formulations are guided by a Medical Advisory Board composed of leading physicians. This team of experts provided insight that helped create a fun, delicious tea with benefits that meets the needs of those who love traditional tea, but are constantly on the move.
“Consumers want wellness that’s simple, enjoyable, and delicious – not complicated or over-engineered,” said Stephanie Schonauer, CMO. “VeryVery gives tea a modern rebrand: bag-free, functional, and full of flavor, built for today’s fast-paced, health-conscious lifestyles while preserving the ritual and wellness people love.”
Energy Tea is available now at veryverygoodtea.com and Amazon, with additional flavors and functional blends planned for release later this year.
About VeryVery Good Tea VeryVery Good Tea was born from a collective of creatives and brand builders who love tea but believed it could be better. Founded by movie producer John Davis, who has incubated and scaled brands like Wetzel’s Pretzels, Blaze Pizza, PopUp Bagels, and Dave’s Hot Chicken, VeryVery Good Tea preserves the ritual and flavor people cherish while removing steep times, leafy water, and hidden microplastics. Based in Los Angeles, VeryVery is modernizing tea for a new generation. Learn more at veryverygoodtea.com.
Jakarta, Pintu News – As of October 22, 2025, Cardano’s ADA token (ADA) is trading at around $0.64, having declined by around 4.7% in the past 24 hours.
Market participants continue to closely monitor technical indicators and institutional developments as the fourth quarter progresses.
Technical Analysis and Institutional Activity
Technical analysis shows that ADA is forming a symmetrical triangle pattern, which often appears before major price movements occur. Currently, the token price is moving in a range between $0.64 to $0.67, with resistance levels around $0.73.
If the price manages to break above that level, ADA has the potential to rise to the range of $0.86 to $1.12. However, if the price drops below $0.61, there is a risk of a further decline towards around $0.50.
Some market watchers highlighted the potential for an upward movement, noting that a successful break of resistance could bring significant gains. One Cardano-focused analyst mentioned that ADA could experience a sizable price spike if the current technical trend continues. However, this projection is speculative and highly dependent on market conditions.
Institutional participation in ADA has also increased, as seen by the token’s inclusion in indices such as the S&P Digital Markets 50. ADA’s daily trading volume occasionally surpasses $1 billion, reflecting increased liquidity.
This has attracted interest from both retail and institutional investors, while the market continues to monitor regulatory developments in the United States that could affect crypto asset valuations.
Cardano Ecosystem Growth and Market Dynamics
The Cardano network continues to expand, with over 2.5 million active addresses and significant progress on the Midnight mainnet development. This update is focused on improving scalability and privacy, to support decentralized finance (DeFi) and non-fungible token (NFT) applications.
Large investors, known as “whales,” have accumulated a significant amount of ADA – approximately 140 million ADA in a three-day period. While this is no guarantee of price direction in the short term, it does provide a snapshot of liquidity distribution and investor behavior.
Overall, the direction in which ADA moves towards the end of 2025 is influenced by technical factors, institutional interest, and the growth of its ecosystem. Market participants remain vigilant on macroeconomic conditions as well as specific developments of the Cardano project that may affect the adoption and usage of the token.
Analysts also caution that the crypto market is highly volatile, and changes in regulation or market sentiment can have a major impact on price movements.
That’s the latest information about crypto. Follow us on Google News to get the latest crypto news about crypto projects and blockchain technology. Also, learn crypto from scratch with complete discussion through Pintu Academy and stay up-to-date with the latest crypto market such as bitcoin price today, xrp coin price today, dogecoin and other crypto asset prices through Pintu Market.
Enjoy an easy and secure crypto trading experience by downloading Pintu crypto app via Google Play Store or App Store now. Also, get a web trading experience with various advanced trading tools such as pro charting, various types of order types, and portfolio tracker only at Pintu Pro.
*Disclaimer
This content aims to enrich readers’ information. Pintu collects this information from various relevant sources and is not influenced by outside parties. Note that an asset’s past performance does not determine its projected future performance. Crypto trading activities have high risk and volatility, always do your own research and use cold cash before investing. All activities of buying and selling bitcoin and other crypto asset investments are the responsibility of the reader.
No news for copper price, to keep providing sideways trading, due to the continuation of the contradiction between the main indicators and the stability below $5.0600 barrier, to increase the chances of forming corrective trading in the near-term period.
Stochastic attempt to provide negative momentum by its exit from the overbought level that might force the price to attack the extra support at $4.7500, while achieving this breach will open the way for achieving extra gains that might begin at $5.2000.
The expected trading range for today is between $4.7500 and $5.0600
Trend forecast: Fluctuated within the bullish track
The GBPJPY pair confirmed the stability of the bullish scenario by forming a new bullish rally yesterday, achieving the initial target by hitting 203.50 level, to settle above $161.8 Fibonacci extension level at 202.50.
The continuation of providing positive momentum by the main indicators will increase the strength of the bullish track, to expect attacking the barrier at 203.95, and surpassing it will open the way for reaching new stations that might begin from 204.60 and 205.25, while changing the trend and begin the bearish corrective track requires forming sharp decline to settle below the extra support at 201.70.
The expected trading range for today is between 202.60 and 203.95
When your supplement stack starts taking up not one, but two shelves in your kitchen, you might have the thought: Can’t I just take a multivitamin?
As a refresher, multivitamins often contain dozens of vitamins and minerals, like B vitamins, calcium, iron, and magnesium. On the other hand, individual supplements contain a single vitamin or mineral. Both types of supplements have their benefits and drawbacks: Multivitamins tend to be more cost effective, but it can be a lot to take eight individual supplements every night.
Meet the experts: Vanessa King, RDN, is a spokesperson for the Academy of Nutrition and Dietetics. Brintha Vasagar, MD, is a family physician based in Milwaukee, Wisconsin.
Ahead, find out the pros and cons of taking multivitamins and individual supplements, and which one you should choose—if either—per a dietitian and doctor.
Multivitamins
Pros
They can help you meet nutrient requirements. “If your diet isn’t well-balanced or your body has trouble absorbing specific nutrients, multivitamins can help you get the elements your body needs to thrive,” says Dr. Vasagar.
They offer extra nutrients. Some people—such as those with health conditions (like inflammatory bowel disease) or who are pregnant or breastfeeding—may have increased nutrient needs, and taking a multivitamin can help, King says. Multivitamins can give you those nutrients in just one capsule.
They’re (relatively) inexpensive. You can pop one pill and get several nutrients, which is more convenient and cost effective than racking up several bottles of individual supplements, according to Harvard Medical School.
Cons
They’re often unnecessary. If you eat a balanced diet and don’t have a nutrient deficiency, you’re probably getting all the nutrients you need, Dr. Vasagar says.
They’re missing some nutrients. Even though they contain a combo of nutrients, multivitamins don’t include everything—for instance, King says they usually don’t include omega-3 fatty acids, which are essential nutrients that your body can’t produce enough of on its own.
They may contain excessive amounts of certain nutrients. Multivitamins contain amounts of vitamins that are generally considered safe, but it’s still possible to get too much of certain nutrients, King says. In most instances, the body will process the excess vitamins, and you’ll pee them out, Dr. Vasagar says. However, fat-soluble vitamins like A, D, E, and K are an exception—they can build up in the body and potentially cause toxicity with symptoms like nausea, fatigue, dizziness, and increase your risk for liver and heart problems, she adds.
Thorne Super EPA Omega-3 Fatty Acids Supplement
Now 10% Off
Momentous Omega-3 Supplement
Now 10% Off
Sports Research Omega-3 Fish Oil
Now 29% Off
NOW Foods DHA-500 Fish Oil Softgels
Nordic Naturals Omega-3 Soft Gels
Now 19% Off
New Chapter Wholemega Fish Oil Supplement
Now 18% Off
Individual Supplements
Pros
They can treat specific deficiencies. “If you’re deficient in one vitamin, it’s best to focus on increasing your dietary intake of that vitamin or taking that specific supplement,” Dr. Vasagar says. A blood test performed by your doctor will identify any deficiencies, and doctors can help you understand how much of a supplement you should take. Similarly, they can help when you need more of a nutrient than a multivitamin provides, King says. For example, during pregnancy, you may need extra iron or folate, or as you get older, you may struggle to absorb vitamin B12, D, and other essential nutrients.
Cons
They may provide too much of a nutrient. If you’re not deficient, individual supplements could provide too much of one vitamin or mineral, Dr. Vasagar says. This could potentially lead to toxicity, which can result in unpleasant symptoms like the ones named above.
You might have to take a lot of pills each day. That could be unpleasant and expensive. “Some find it easier to stick with a multi rather than multiple single nutrients” for those reasons, King says.
So, which type of supplement should you choose?
If you eat a healthy, balanced diet and don’t have a nutrient deficiency, you likely don’t need to take any supplements at all, Dr. Vasagar says. But a few groups are at a high risk for deficiencies and may need a multivitamin or individual supp:
Pregnant people. They’re encouraged to take prenatal vitamins, a type of multivitamin which typically includes B vitamins, calcium, iron, and more, King says. Doctors recommend these vitamins for healthy fetal growth and development, and to minimize pregnancy complications.
Babies and children.Pediatricians often recommend that babies take vitamin D supplements. Kids who eat little to no meat should take a multivitamin with iron, and those who don’t eat animal products should take vitamin B12 and iron, per the Boston Children’s Hospital. Children who don’t eat dairy or much calcium should opt for calcium and vitamin D supplements, and those who don’t eat many fruits or vegetables, or lack other key nutrients, may need a multivitamin.
People over 60. Nutrient absorption can decline as you age, which can lead to deficiencies, such as in calcium or vitamin B12. Taking a multivitamin or individual supplements could help, Dr. Vasagar says.
People with restrictive diets. If you avoid certain food groups, such as meat or dairy, you may need to supplement nutrients like calcium or vitamin B12, either via a multivitamin or individual supplement, Dr. Vasagar says.
Just make sure to check in with your doctor or a registered dietitian if you’re worried about a nutrient deficiency or are unsure which vitamins or supplements to take, King says.
Best Practices For Supplementation: If you want to take any supp, always read the product label. “Some vitamins may contain megadoses many times greater than your daily needs,” says King. And if you opt for a multivitamin, check that it contains the right amounts of the specific vitamins or minerals you need. Also note that supplements aren’t regulated by the U.S. Food and Drug Administration the way medications are, she says. Look for items with third-party certifications from NSF International, USP, and other organizations; that way, they will have been tested to make sure they contain only the nutrients you need.
Supplements can definitely be helpful in some cases, King says. But the best way to go? Consuming a balanced diet full of all the nutrients that will help keep you healthily moving and grooving.
Erica Sweeney is a writer who mostly covers health, wellness and careers. She has written for The New York Times, HuffPost, Teen Vogue, Parade, Money, Business Insider and many more.
